| Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery J Nicolas, S Mura, D Brambilla, N Mackiewicz, P Couvreur Chemical Society Reviews 42 (3), 1147-1235, 2013 | 960 | 2013 |
| Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues D Brambilla, B Le Droumaguet, J Nicolas, SH Hashemi, LP Wu, ... Nanomedicine: Nanotechnology, Biology and Medicine 7 (5), 521-540, 2011 | 262 | 2011 |
| Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer’s disease B Le Droumaguet, J Nicolas, D Brambilla, S Mura, A Maksimenko, ... ACS nano 6 (7), 5866-5879, 2012 | 125 | 2012 |
| PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer’s disease D Brambilla, R Verpillot, B Le Droumaguet, J Nicolas, M Taverna, J Kóna, ... ACS nano 6 (7), 5897-5908, 2012 | 123 | 2012 |
| Breakthrough discoveries in drug delivery technologies: the next 30 years D Brambilla, P Luciani, JC Leroux Journal of Controlled Release 190, 9-14, 2014 | 79 | 2014 |
| Design of fluorescently tagged poly (alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging D Brambilla, J Nicolas, B Le Droumaguet, K Andrieux, V Marsaud, ... Chemical communications 46 (15), 2602-2604, 2010 | 56 | 2010 |
| 3D printing of a wearable personalized oral delivery device: A first-in-human study K Liang, S Carmone, D Brambilla, JC Leroux Science advances 4 (5), eaat2544, 2018 | 54 | 2018 |
| New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide D Brambilla, R Verpillot, M Taverna, L De Kimpe, B Le Droumaguet, ... Analytical chemistry 82 (24), 10083-10089, 2010 | 53 | 2010 |
| Novel isoprenoyl nanoassembled prodrug for paclitaxel delivery S Mura, F Zouhiri, S Lerondel, A Maksimenko, J Mougin, C Gueutin, ... Bioconjugate chemistry 24 (11), 1840-1849, 2013 | 36 | 2013 |
| Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model D Carradori, C Balducci, F Re, D Brambilla, B Le Droumaguet, O Flores, ... Nanomedicine: Nanotechnology, Biology and Medicine 14 (2), 609-618, 2018 | 32 | 2018 |
| Quantum dot-loaded PEGylated poly (alkyl cyanoacrylate) nanoparticles for in vitro and in vivo imaging J Nicolas, D Brambilla, O Carion, T Pons, I Maksimovic, E Larquet, ... Soft Matter 7 (13), 6187-6193, 2011 | 26 | 2011 |
| Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages A Orlando, F Re, S Sesana, I Rivolta, A Panariti, D Brambilla, J Nicolas, ... International Journal of Nanomedicine 8, 1335, 2013 | 22 | 2013 |
| Pharmacokinetics of lipid-drug conjugates loaded into liposomes RD Signorell, P Luciani, D Brambilla, JC Leroux European journal of pharmaceutics and biopharmaceutics 128, 188-199, 2018 | 18 | 2018 |
| Application of nanomedicine to the CNS diseases D Carradori, A Gaudin, D Brambilla, K Andrieux International review of neurobiology 130, 73-113, 2016 | 16 | 2016 |
| Selegiline-functionalized, PEGylated poly (alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization B Le Droumaguet, H Souguir, D Brambilla, R Verpillot, J Nicolas, ... International journal of pharmaceutics 416 (2), 453-460, 2011 | 15 | 2011 |
| Poly (2-oxazoline)–Pterostilbene block copolymer nanoparticles for dual-anticancer drug delivery M Romio, G Morgese, L Trachsel, S Babity, C Paradisi, D Brambilla, ... Biomacromolecules 19 (1), 103-111, 2018 | 13 | 2018 |
| The effect of settling on cytotoxicity evaluation of SiO2 nanoparticles A Spyrogianni, GA Sotiriou, D Brambilla, JC Leroux, SE Pratsinis Journal of Aerosol Science 108, 56-66, 2017 | 13 | 2017 |
| Nanoparticles against Alzheimer's disease: PEG–PACA nanoparticles are able to link the aβ-peptide and influence its aggregation kinetic D Brambilla, R Verpillot, L De Kimpe, M Taverna, B Le Droumaguet, ... Journal of Controlled Release 148 (1), e112-e113, 2010 | 13 | 2010 |
| Is 3D printing of pharmaceuticals a disruptor or enabler? K Liang, D Brambilla, JC Leroux Advanced Materials 31 (5), 1805680, 2019 | 12 | 2019 |
| Advances in the design of transdermal microneedles for diagnostic and monitoring applications S Babity, M Roohnikan, D Brambilla Small 14 (49), 1803186, 2018 | 11 | 2018 |
Couvreur PUniversité Paris-Sud XIVerified email at u-psud.fr
